SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001341004-13-001211
Filing Date
2013-11-19
Accepted
2013-11-19 17:13:31
Documents
6
Effectiveness Date
2013-11-19

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14A dfan14a.htm DFAN14A 72930
2 PRESS RELEASE LOGOS logos.jpg GRAPHIC 13036
3 dfan14a0.jpg GRAPHIC 930
4 dfan14a1.jpg GRAPHIC 891
5 dfan14a2.jpg GRAPHIC 918
6 dfan14a3.jpg GRAPHIC 1015
  Complete submission text file 0001341004-13-001211.txt   98192
Mailing Address 2100 SYNTEX COURT MISSISSAUGA A6 L5N 7K9
Business Address C/O PATHEON PHARMACEUTICALS SERVICES INC 4721 EMPEROR BOULEVARD, SUITE 200 DURHAM NC 27703 905-821-4001
PATHEON INC (Subject) CIK: 0001400431 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1031
Type: DFAN14A | Act: 34 | File No.: 000-54283 | Film No.: 131230787
SIC: 2834 Pharmaceutical Preparations

Mailing Address 450 LEXINGTON AVE., 31ST FLOOR NEW YORK NY 10017
Business Address 450 LEXINGTON AVE., 31ST FLOOR NEW YORK NY 10017 (212) 286-8600
JLL Associates V (Patheon), L.P. (Filed by) CIK: 0001518967 (see all company filings)

IRS No.: 273062528 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DFAN14A